Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company is headquartered in Tianjin, Tianjin and currently employs 86 full-time employees. The company went IPO on 2006-05-23. The Company’s main business is engaged in producing and distributing Reconstituted Bone Xenograft (RBX). The RBX is a medical device that accelerates bone healing. The firm distributes its medical devices to hospitals as well as other medical device customers that are not hospitals.
How did GENX's recent EPS compare to expectations?
The most recent EPS for Genex Pharmaceutical Inc is $, expectations of $.
How did Genex Pharmaceutical Inc GENX's revenue perform in the last quarter?
Genex Pharmaceutical Inc revenue for the last quarter is $
What is the revenue estimate for Genex Pharmaceutical Inc?
According to of Wall street analyst, the revenue estimate of Genex Pharmaceutical Inc range from $ to $
What's the earning quality score for Genex Pharmaceutical Inc?
Genex Pharmaceutical Inc has a earning quality score of B/41.194542. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Genex Pharmaceutical Inc report earnings?
Genex Pharmaceutical Inc next earnings report is expected in
What are Genex Pharmaceutical Inc's expected earnings?
Genex Pharmaceutical Inc expected earnings is $, according to wall-street analysts.
Did Genex Pharmaceutical Inc beat earnings expectations?
Genex Pharmaceutical Inc recent earnings of $ expectations.